Safety Alerts and Products Recalls > Products found to contain undeclared medicines

Products found to contain undeclared medicines   Australia: Safety advisory: Zhansheng Weige Cahoyue Xilishi tablets was found to contain undeclared prescription substance sildenafil   The Therapeutic Goods Administration has tested a product labelled Zhansheng Weige Cahoyue Xilishi tablets and found that it contains the undeclared prescription substance sildenafil. Consumers are advised to stop taking Zhansheng Weige Cahoyue Xilishi tablets and take any remaining tablets to their local pharmacy for safe disposal and consult their healthcare practitioner if they have any concerns arising from their use of this product. Please refer to the following website in TGA for details: http://www.tga.gov.au/safety/alerts-medicine-zhansheng-weige-cahoyue-xilishi-140514.htm In Hong Kong, the above product is not a registered pharmaceutical product. Ends/ Wednesday, May 14, 2014 Issued at HKT 15:00   Related Information: Canada: Foreign Product Alerts: Zhansheng Weige Chaoyue Xilishi, Chong Cao Zhag ... Posted 2014-12-31 The United States: Public Notification: Zhansheng Weige Chaoyue Xilishi contains... Posted 2014-12-24 Australia: Safety Advisory: MMC Sex Men capsule was found to contain undeclared ... Posted 2014-09-03 Canada: Foreign Product Alerts: MV5 Days, S.W.A.G, Zhansheng Weige Cahoyue Xilis... Posted 2014-08-12 The United States: Public Notification: Arize was found to contain undeclared dr... Posted 2014-08-12 The United States: Public Notification: Herbal Vigor Quick Fix was found to cont... Posted 2014-08-12 The United States: Public Notification: O.M.G. was found to contain undeclared d... Posted 2014-07-23 Australia: Safety advisory - Zhansheng Weige Chaoyue Xilishi tablet was found to... Posted 2014-07-19